-
461
Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies
Published 2025-01-01Subjects: “…cancer immunotherapy (CIT)…”
Get full text
Article -
462
Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells
Published 2012-02-01Subjects: Get full text
Article -
463
Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
Published 2025-01-01Subjects: “…adjuvant immunotherapy…”
Get full text
Article -
464
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
Published 2025-02-01Subjects: Get full text
Article -
465
-
466
Catalysts of change: Immunotherapy's frontier in oral oncology
Published 2024-09-01Subjects: Get full text
Article -
467
Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
Published 2024-12-01Subjects: Get full text
Article -
468
-
469
-
470
Paradoxical control of multifocal mammary oncogenesis by radiation therapy
Published 2025-12-01Subjects: Get full text
Article -
471
The role of immunotherapy in the treatment of lip squamous cell carcinoma: A series of six cases and a review of the current literature
Published 2024-06-01Subjects: Get full text
Article -
472
Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
473
Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
Published 2024-03-01Subjects: Get full text
Article -
474
-
475
A Turbo‐Charging System‐Like Contrast Agent for MRI‐Guided STING Pathway‐Activated Cancer Immunotherapy
Published 2025-01-01Subjects: “…cancer immunotherapy…”
Get full text
Article -
476
Oncological principles in the management of ocular surface squamous neoplasia - A Review
Published 2025-02-01Subjects: Get full text
Article -
477
Natural killer cell engagers for cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
478
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
Published 2024-02-01Subjects: Get full text
Article -
479
Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
Published 2025-01-01Subjects: Get full text
Article